Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy

BACKGROUND: Early diagnosis of pancreatic ductal adenocarcinoma (PDAC) is challenged by the absence of accurate early diagnostic and prognostic biomarkers. CA19-9 is the established, diagnostic tumour marker in PDAC, despite its limitations. Effective primary screening using circulating biomarker pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruger, Deirdré, Yako, Yandiswa Y., Devar, John, Lahoud, Nicola, Smith, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695103/
https://www.ncbi.nlm.nih.gov/pubmed/31415645
http://dx.doi.org/10.1371/journal.pone.0221169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695103/
https://www.ncbi.nlm.nih.gov/pubmed/31415645
http://dx.doi.org/10.1371/journal.pone.0221169

Ejemplares similares